Changlei Xia – Trademark Portfolio

Entity Type: 01

Changlei Xia holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 6 (Metal Goods) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include JOLVA and QLEOVO. The owner is based in Shangrao City, Jiangxi.

Luoqiao Sub-dist. Office,Shangrao County

No.104, CunShang Xiazhang, Zhangcun Vill

Shangrao City, Jiangxi 334100 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

QLEOVO
QLEOVO
Registered 2024
JOLVA
JOLVA
Registered 2024

Trademark Classifications

Changlei Xia's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Changlei Xia have?

Changlei Xia has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Changlei Xia file in?

Changlei Xia files trademarks across 2 Nice Classification classes. The most active classes are Class 6 (Metal Goods), Class 5 (Pharmaceuticals). Class 6 covers common metals and their alloys; metal building materials; transportable buildings of metal.

What are Changlei Xia's most well-known trademarks?

Changlei Xia's registered trademark portfolio includes well-known marks such as JOLVA and QLEOVO. These are among 2 currently registered trademarks in the portfolio.

What is Changlei Xia's trademark registration success rate?

Changlei Xia has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.